U
CLMT icon

UBS’s Calumet Specialty Products CLMT Stock Holding History

UBS’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16.5M Buy
599,950
+40,364
+7% +$1.22M 0.01% 1077
2014
Q2 		$17.8M Sell
559,586
-38,160
-6% -$1.14M 0.01% 953
2014
Q1 		$15.4M Buy
597,746
+40,097
+7% +$1.09M 0.01% 953
2013
Q4 		$14.5M Buy
557,649
+118,619
+27% +$3.31M 0.01% 1007
2013
Q3 		$12M Buy
439,030
+20,812
+5% +$654K 0.01% 995
2013
Q2 		$15.2M Buy
+418,218
New +$15M 0.02% 792

Other funds holding CLMT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
IMS
Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $217M AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

UBS's CLMT Position: Q3 2014 in Review

UBS increased its Calumet Specialty Products (CLMT) stake by 7.2% in Q3 2014, buying an estimated $1.22M and bringing the position to 599,950 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1077.

UBS first reported a position in CLMT in Q2 2013 and has held it in 6 quarters since. The position peaked at $17.8M in Q2 2014. 115 funds tracked by Wall St. Rank hold CLMT as of Q3 2014.

  • UBS held 599,950 shares of Calumet Specialty Products worth $16.5M as of Q3 2014.
  • UBS bought 40,364 Calumet Specialty Products shares in Q3 2014, an estimated $1.22M.
  • Calumet Specialty Products made up 0.01% of UBS's portfolio in Q3 2014, its #1077 holding.
  • UBS first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 6 quarters since.
  • UBS's Calumet Specialty Products position peaked at $17.8M in Q2 2014.
  • 115 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.